184 related articles for article (PubMed ID: 30723079)
1. Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study.
Hsi ED; Li H; Nixon AB; Schöder H; Bartlett NL; LeBlanc M; Smith S; Kahl BS; Leonard JP; Evens AM; Scott DW; Rimsza LM; Friedberg JW
Blood; 2019 Apr; 133(16):1762-1765. PubMed ID: 30723079
[TBL] [Abstract][Full Text] [Related]
2. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC.
Plattel WJ; Alsada ZN; van Imhoff GW; Diepstra A; van den Berg A; Visser L
Br J Haematol; 2016 Dec; 175(5):868-875. PubMed ID: 27610595
[TBL] [Abstract][Full Text] [Related]
4. CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma.
Cuccaro A; Annunziata S; Cupelli E; Martini M; Calcagni ML; Rufini V; Giachelia M; Bartolomei F; Galli E; D'Alò F; Voso MT; Leone G; Giordano A; Larocca LM; Hohaus S
Cancer Med; 2016 Mar; 5(3):398-406. PubMed ID: 26758564
[TBL] [Abstract][Full Text] [Related]
5. Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy.
Viviani S; Mazzocchi A; Pavoni C; Taverna F; Rossi A; Patti C; Romano A; Trentin L; Sorasio R; Guidetti A; Gottardi D; Tarella C; Cimminiello M; Zanotti R; Farina L; Ferreri AJM; Galbiati M; Corradini P; Gianni AM; Gallamini A; Rambaldi A
Hematol Oncol; 2020 Oct; 38(4):501-508. PubMed ID: 32602970
[TBL] [Abstract][Full Text] [Related]
6. Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by PET scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma.
Farina L; Rezzonico F; Spina F; Dodero A; Mazzocchi A; Crippa F; Alessi A; Dalto S; Viviani S; Corradini P
Biol Blood Marrow Transplant; 2014 Dec; 20(12):1982-8. PubMed ID: 25240818
[TBL] [Abstract][Full Text] [Related]
7. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
Niens M; Visser L; Nolte IM; van der Steege G; Diepstra A; Cordano P; Jarrett RF; Te Meerman GJ; Poppema S; van den Berg A
Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
[TBL] [Abstract][Full Text] [Related]
8. US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
Press OW; Li H; Schöder H; Straus DJ; Moskowitz CH; LeBlanc M; Rimsza LM; Bartlett NL; Evens AM; Mittra ES; LaCasce AS; Sweetenham JW; Barr PM; Fanale MA; Knopp MV; Noy A; Hsi ED; Cook JR; Lechowicz MJ; Gascoyne RD; Leonard JP; Kahl BS; Cheson BD; Fisher RI; Friedberg JW
J Clin Oncol; 2016 Jun; 34(17):2020-7. PubMed ID: 27069074
[TBL] [Abstract][Full Text] [Related]
9. Thymus and activation-regulated chemokine (TARC) as treatment response marker for paediatric Hodgkin lymphoma: A pilot study.
Zijtregtop EAM; Diez C; Zwaan CM; Veening MA; Beishuizen A; Meyer-Wentrup FAG
Br J Haematol; 2023 Jan; 200(1):70-78. PubMed ID: 36128637
[TBL] [Abstract][Full Text] [Related]
10. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis.
Wang J; Zhao Q; Wang G; Yang C; Xu Y; Li Y; Yang P
Cytokine; 2016 May; 81():10-4. PubMed ID: 26827189
[TBL] [Abstract][Full Text] [Related]
12. Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma.
Guidetti A; Mazzocchi A; Miceli R; Paterno' E; Taverna F; Spina F; Crippa F; Farina L; Corradini P; Gianni AM; Viviani S
Leuk Res; 2017 Nov; 62():91-97. PubMed ID: 28992524
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis.
Horikawa T; Nakayama T; Hikita I; Yamada H; Fujisawa R; Bito T; Harada S; Fukunaga A; Chantry D; Gray PW; Morita A; Suzuki R; Tezuka T; Ichihashi M; Yoshie O
Int Immunol; 2002 Jul; 14(7):767-73. PubMed ID: 12096036
[TBL] [Abstract][Full Text] [Related]
14. Production of TARC and MDC by naive T cells in asthmatic patients.
Hirata H; Arima M; Cheng G; Honda K; Fukushima F; Yoshida N; Eda F; Fukuda T
J Clin Immunol; 2003 Jan; 23(1):34-45. PubMed ID: 12645858
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma.
Marri PR; Hodge LS; Maurer MJ; Ziesmer SC; Slager SL; Habermann TM; Link BK; Cerhan JR; Novak AJ; Ansell SM
Clin Cancer Res; 2013 Dec; 19(24):6812-9. PubMed ID: 24141626
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD163 serum levels are elevated and correlated with IL-12 and CXCL10 in patients with long-standing rheumatoid arthritis.
Jude C; Dejica D; Samasca G; Balacescu L; Balacescu O
Rheumatol Int; 2013 Apr; 33(4):1031-7. PubMed ID: 23011084
[TBL] [Abstract][Full Text] [Related]
17. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
Shimada Y; Takehara K; Sato S
J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
[TBL] [Abstract][Full Text] [Related]
18. Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant.
Harrison SJ; Hsu AK; Neeson P; Younes A; Sureda A; Engert A; Prince HM; Li M; Savage P; Bugarini R; Williams D; Squier M; Ritchie DS
Leuk Lymphoma; 2014 May; 55(5):1053-60. PubMed ID: 23822537
[TBL] [Abstract][Full Text] [Related]
19. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Hartl D; Latzin P; Zissel G; Krane M; Krauss-Etschmann S; Griese M
Am J Respir Crit Care Med; 2006 Jun; 173(12):1370-6. PubMed ID: 16543550
[TBL] [Abstract][Full Text] [Related]
20. Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases.
Echigo T; Hasegawa M; Shimada Y; Inaoki M; Takehara K; Sato S
Arch Dermatol Res; 2006 Jun; 298(1):38-45. PubMed ID: 16583210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
